AKT1 and glioblastoma: Dedicated inhibitors of the mTORC1 complex are known to drive feedback loops leading to activation of the upstream driver Akt, which may yield even greater malignant behavior; however, DGKα inhibition has been shown to suppress Akt as well as mTOR activity in GBM cells [21].